Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Stock
Healthcare · Biotechnology · SG
$3.51
+31.95%
Last updated Aug 3, 2026 04:25 UTC
CUPR Key Statistics
Market Cap$75.10M
P/E (TTM)—
P/S (TTM)—
P/B (TTM)-17.12
Revenue (TTM)$0.00
EPS (TTM)—
Dividend Yield—
ROE (TTM)42.42%
Net Margin-3,229.52%
Gross Margin-6.26%
52W High$14.80
52W Low$0.28
Analyst View—
Price Target—
Employees15
Volume517,414
About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds. The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds. Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.
CEO: Yong Qi Quek. Company website
See CUPR live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open CUPR in Terminal See plans